Mon. 28 May, 2012 - Sun. 3 Jun, 2012
Tue. 29 May, 2012
UCMR Mini-Symposium
Tue. 29 May, 2012 8:30 - 11:45
UCMR Mini-Symposium
Research projects and networks at the Laboratories for Chemical Biology Umeå (LCBU) and X-ray crystallography research within UCMR research groups.
The symposium is open to everyone and no registration is required.
Place: Lilla hörsalen, KB3A9, KBC
Programme
Research projects and networks at the Laboratories for Chemical Biology Umeå (LCBU) and X-ray crystallography research within UCMR research groups.
The symposium is open to everyone and no registration is required.
Place: Lilla hörsalen, KB3A9, KBC
ProgrammeSeminar - Leonor David: Regulation of mucin glycoproteome in gastric carcinogenesis
Tue. 29 May, 2012 15:15
Medical Biochemistry and Biophysics Seminar Series, spring 2012
Leonor David, IPATIMUP, Medical Faculty of the University of Porto, Portugal
"Regulation of mucin glycoproteome in gastric carcinogenesis"
Place: Lecture hall KB3A9, Lilla hörsalen, KBC
Host: Thomas Borén
Leonor David, IPATIMUP, Medical Faculty of the University of Porto, Portugal
"Regulation of mucin glycoproteome in gastric carcinogenesis"
Place: Lecture hall KB3A9, Lilla hörsalen, KBC
Host: Thomas Borén
Thu. 31 May, 2012
Video-Transfer-Seminar - John Overington: A data mining synthesis approach to the discovery of impersonalised, robust and safe therapies
Thu. 31 May, 2012 10:30 - 11:30
EMBL Partnership for Molecular Medicine (FIMM - MIMS - NCMM) joint Special Seminar at the Biomedicum in Helsinki.
Video transfer of the talk to Umeå and Oslo simultanously.
John Overington, EMBL Outstation - Hinxton, European Bioinformatics Institute, Cambridge, UK
"A data mining synthesis approach to the discovery of impersonalised, robust and safe therapies"
Abstract:
Adverse Drug Reactions, ADRs, are a major burden on healthcare systems, and arguably, if patients can be stratified, more novel therapies, tolerable in particular genotyped groups could be developed and launched. We have taken a data synthesis approach to explore ADRs and some of the underlying molecular recognition and pharmacokinetic concepts. We then derived a novel drug combination strategy which theoretically can greatly improve the safety of current therapies and also lead to more predictable and consistent patient population response.
Summary for downloadPlace: Major Groove, Department of Molecular Biology, bldg 6L, University Hospital Area
Organizer in Sweden: Åke Forsberg
Host at FIMM in Finland: Heidi Virtanen
Fri. 1 Jun, 2012
Seminar - Jürg Müller: Molecular mechanisms of the Polycom/trithorax system
Fri. 1 Jun, 2012 15:00
The "National and International" Seminar Series, spring 2012
Jürg Müller, Max Planck Institute of Biochemistry, Martinsried, Germany
"Molecular mechanisms of the Polycom/trithorax system"
Place: Lecture hall Betula, bldg. 6M, NUS
Host: Yuri Schwartz, Molecular Biology
Jürg Müller, Max Planck Institute of Biochemistry, Martinsried, Germany
"Molecular mechanisms of the Polycom/trithorax system"
Place: Lecture hall Betula, bldg. 6M, NUS
Host: Yuri Schwartz, Molecular Biology